U.S. Energy Services Stock News

If you are wondering whether Generac Holdings' share price still reflects good value after its recent run, you are not alone. The stock last closed at US$182.30, with returns of 5.2% over 7 days, 19.3% over 30 days, 29.2% year to date, 28.6% over 1 year, 45.6% over 3 years and a 48.0% decline over 5 years. This performance raises questions about how to think about risk and reward today. Recent news coverage has focused on Generac's role in backup power and energy solutions as investors...

In early February 2026, Sigma Lithium reported that Brazil’s mining regulator issued an official statement confirming the safety of its waste piles after inspections, while the company resumed mining at Mine 1 and outlined new production guidance for 2026 and 2027. This regulatory validation, together with operational restart and financing supported by sales of dry-stacked lithium fines, directly addresses prior misinformation and operational uncertainty around the business. We’ll now...

Palantir Technologies (NasdaqGS:PLTR) has extended its multi-year partnership with Airbus to keep powering the Skywise aviation data platform. The renewed agreement focuses on migrating Skywise to sovereign cloud environments to help meet regulatory and data governance requirements. The deal reinforces Palantir’s role in large scale industrial data platforms used in mission critical aerospace operations. For you as an investor, this relates to how Palantir’s software is used in real world...

Comstock Resources (CRK) is set to report quarterly earnings on February 11, 2026, an event drawing attention as investors weigh its 47.75% revenue growth versus peers against higher debt and an expected EPS of $0.11. See our latest analysis for Comstock Resources. At a share price of $20.42, Comstock Resources has seen a 9.12% decline in its 7 day share price return and a 19.03% decline over 90 days. However, its 1 year total shareholder return of 10.86% and 5 year total shareholder return...

Why Versant Media Group Is On Investors’ Radar Today Versant Media Group (VSNT) has drawn fresh attention after a period of weak share performance, with the stock down about 16% over the past month and around 38% year to date. For investors tracking U.S. media names, this recent slide, alongside reported revenue of $6,801 and net income of $1,125, raises questions about how the company’s cable networks and digital platforms are being valued in today’s market. See our latest analysis for...

What Regeneron’s Recent Trading Says About Investor Focus Regeneron Pharmaceuticals (REGN) has seen mixed share performance recently, with a 3.3% decline over the past day and a small slip over the past week, but a positive move across the past 3 months. Over the past month the stock has fallen about 5.2%, while its 1 year total return of 14.1% and 5 year total return of 57.9% highlight a very different picture for longer term holders. See our latest analysis for Regeneron...

Recent commentary around Prologis (PLD) has zeroed in on two forces pulling in different directions: softer 2025 logistics rents with talk of a rebound in 2026, and renewed attention on legal risks. See our latest analysis for Prologis. The recent mix of legal headlines and new data center partnerships comes against a backdrop of firm share price momentum, with a 30 day share price return of 8.56% and a 1 year total shareholder return of 19.47% suggesting that investors are reassessing both...

Event context and recent performance snapshot Franklin Resources (BEN) has drawn fresh attention after recent trading, with the share price at $28.16 and total return figures of 18.3% year to date and 47.8% over the past year. See our latest analysis for Franklin Resources. The recent 1-day share price return of 1.73% and 90-day share price return of 22.17% sit alongside a 1-year total shareholder return of 47.79%, suggesting momentum has been building rather than fading. If Franklin...

If you are wondering whether JFrog shares at about US$53.20 still offer value, you are not alone. This article breaks down what that price might really represent. The stock has been volatile, with a 2.7% return over the last 7 days, a 10.2% decline over 30 days, a 10.7% decline year to date, and a 48.0% return over 1 year, alongside a 119.8% return over 3 years and a 23.2% decline over 5 years. Recent coverage of JFrog has focused on its role in software development tooling and how investors...

KBR (KBR) is back in focus after a run of new U.S. defense and space contracts, including firm-fixed-price awards totaling US$103 million and an additional US$77 million task order from the U.S. Space Force. See our latest analysis for KBR. Despite the fresh U.S. defense and space awards, KBR’s recent trading tells a mixed story, with an 8.12% year to date share price return contrasting with a 1 year total shareholder return decline of 18.90%. This hints at improving short term momentum...

If you are wondering whether Kimco Realty's current share price lines up with its underlying value, this article will walk through what the numbers are saying and where the market might be getting ahead of itself or selling it short. Kimco Realty shares recently closed at US$22.19, with returns of 6.2% over 7 days, 8.7% over 30 days, 10.6% year to date, 4.0% over 1 year, 19.8% over 3 years and 55.9% over 5 years. This gives useful context before you weigh up the valuation. Recent coverage on...

In early February 2026, PTC Inc. reported first-quarter fiscal 2026 results showing higher revenue and earnings compared to a year earlier, raised its full-year 2026 revenue and earnings guidance, and confirmed it had repurchased about 2.33% of its shares under a buyback announced in November 2024. This combination of stronger recent performance, more optimistic full-year forecasts, and an ongoing capital return program highlights how management is aligning operational progress with...

Why Celanese’s Latest Price Moves Matter for Investors Celanese (CE) is raising prices for acetic acid, vinyl acetate monomer, and related derivatives across the Western Hemisphere, a change that takes effect immediately or as existing contracts allow. For you as an investor, this type of pricing shift can influence revenue mix, margins, and customer relationships, especially in segments where Celanese supplies key inputs into industrial and consumer applications. See our latest analysis for...

Analyst coverage sparks fresh attention on NextDecade Capital One Financial has initiated coverage on NextDecade (NEXT) with a buy rating, putting fresh attention on the liquefied natural gas developer and its Rio Grande LNG and carbon capture projects in Texas. See our latest analysis for NextDecade. NextDecade's share price has climbed 6.3% over the past week and 10.0% over the past month to US$5.38, although the 1 year total shareholder return shows a 32.1% decline and the 5 year total...

In the past week, Edwards Lifesciences reported Q4 2025 sales of US$1,569.6 million and full-year 2025 sales of US$6.07 billion, alongside issuing 2026 guidance calling for first-quarter sales of US$1.55 billion to US$1.63 billion and full-year EPS of US$2.90 to US$3.05. While revenue continued to grow, the sharp drop in quarterly and full-year net income and EPS highlights how margin pressure and one-off factors are shaping Edwards’ profit profile as it invests behind its Structural Heart...

Pinterest (NYSE:PINS) has appointed Kecia Steelman, CEO of Ulta Beauty, to its Board of Directors. The company is rolling out a global restructuring plan that includes workforce and office space reductions. Management is prioritizing investment in AI technology to support shopping and visual discovery on the platform. Pinterest runs a visual discovery and social media platform built around images, search and idea curation, with a growing focus on shopping experiences. Across the sector,...

In early February 2026, Iovance Biotherapeutics reported real-world data for its commercial Amtagvi (lifileucel) therapy in advanced melanoma, showing what it called a best-in-class profile with unprecedented response rates, while reiterating extensive regulatory, manufacturing, and commercialization risks in its latest disclosures. The company’s detailed risk discussion highlights how fragile this apparent clinical success could be, with uncertainties around ex-U.S. approvals, manufacturing...

Recent coverage around potential US cannabis regulatory shifts, including possible rescheduling to Schedule III and the SAFER Act, has brought Innovative Industrial Properties (IIPR) back into focus for income oriented real estate investors. See our latest analysis for Innovative Industrial Properties. IIPR’s latest share price of $47.99 sits against a backdrop of a 30 day share price return of 5.16% and a year to date share price return of 2.99%. The 1 year total shareholder return of 25.89%...

With no fresh headline driving Hershey (HSY) today, the stock’s recent performance still stands out, with gains over the month, past 3 months, year to date, and the past year drawing investor attention. See our latest analysis for Hershey. Hershey’s recent 30 day share price return of 21.12% and 90 day share price return of 28.46%, against a 1 year total shareholder return of 49.44%, point to momentum building again after a softer multi year profile. If this move has you thinking about where...

In early February 2026, JPMorgan reiterated its positive stance on DLocal, citing record Total Payment Volume and gross profit alongside expanding cross-border payments infrastructure and new offerings like its Buy Now, Pay Later Fuse across multiple emerging markets. The analyst commentary underscored that DLocal’s growing network of local payment methods and product breadth is becoming a key differentiator for merchants seeking access to diverse, cash-light economies. Next, we’ll examine...

Alvotech (ALVO) shares have been in focus after the company reported positive top line pharmacokinetic data for its AVT80 biosimilar candidate to Entyvio, along with new supply and commercialization agreements with Sandoz in Canada, Australia and New Zealand. See our latest analysis for Alvotech. These fresh clinical results and the Sandoz agreements come after a mixed share price pattern, with a 12.07% 1 month share price return and a 4.00% year to date share price return contrasting with a...

Qiagen (NYSE:QGEN) has launched new automation platforms for DNA and RNA extraction in clinical laboratories. The line up includes sustainability focused consumables, QIAsprint Connect, QIAsymphony Connect, and QIAmini. The products target a wide range of clinical and research settings that rely on scalable sample preparation workflows. Qiagen, trading at $51.08, is putting fresh attention on lab automation and sustainability with this new product wave. The company’s shares have returned...

Recent share performance and business profile Science Applications International (SAIC) has been in focus for investors after a month return of about a 14% decline, contrasting with an 8.3% gain over the past 3 months and a 5 year total return of 11.8%. The Reston based contractor generates about US$7.35b in annual revenue and US$371m in net income, providing technical, engineering and enterprise IT services across U.S. defense, intelligence and civilian agencies. See our latest analysis for...

Bausch Health Companies has recently attracted renewed investor attention as it works to cut its sizeable debt, address legacy legal issues, and reshape its portfolio across eye health and specialty pharmaceuticals. An interesting angle is how growing social media visibility of Bausch’s key brands is drawing in more retail investors and amplifying interest in its ongoing turnaround efforts. We’ll now examine how this increased focus on Bausch’s debt reduction progress and turnaround...